Opyl Limited (OPL.AX)

0.0240 +0.0010 (+4.35%) At close: 03:35PM AEST

Opyl Limited

6 Middlemiss Street
Milsons Point, NSW 2061
Australia

https://www.opyl.ai

Sector(s): Healthcare
Industry: Health Information Services
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Saurabh Jain	Interim CEO & Executive Chairman	150k	N/A	N/A
Mr. Mark Ziirsen	Chief Financial Officer	229.43k	N/A	1963
Mr. Damon Rasheed	CTO & Executive Director	27.78k	N/A	N/A
Mr. Shane Lewis	Vice President of Sales & Partnerships	N/A	N/A	N/A
Mr. Scott Sorochak	Chief Revenue Officer	N/A	N/A	N/A
Mr. Jonathan Hart B.Com., L.L.B.	Company Secretary	N/A	N/A	1984

Amounts are as of 31 December 2024, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Opyl Limited engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process for biopharma, MedTech, government, and healthcare organizations. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in Milsons Point, Australia.

Corporate governance

Opyl Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.